论文部分内容阅读
目的:探讨早期肠内营养支持在急性重症胰腺炎治疗的疗效评价。方法:选择84例急性重症胰腺炎患者,随机分为对照组和治疗组,各42例。对照组采取常规治疗,治疗组采取早期肠内营养支持,比较两组的住院时间、感染率、并发症和生化指标。结果:治疗组的住院时间、住院费用分别为(23.83±5.91)d、(3.12±1.66)万元,感染率为28.6%,并发症发生率为35.7%,均显著低于对照组,比较差异具有统计学意义(P<0.05)。治疗组的生化指标白蛋白检验在治疗前后均无统计学意义(P>0.05)。治疗组的血淀粉酶、AST、血糖在治疗后的14d,均有明显的改善,比较差异具有统计学意义(P<0.05)。结论:早期肠内营养支持在急性重症胰腺炎的治疗中,能有效降低并发症的发生,患者的营养状况得到良好的改善,促进病情恢复,是安全、有效的治疗方法,值得推广。
Objective: To evaluate the efficacy of early enteral nutrition support in the treatment of acute severe pancreatitis. Methods: Eighty-four patients with acute severe pancreatitis were randomly divided into control group and treatment group, with 42 cases in each group. The control group was treated routinely, and the treatment group received early enteral nutrition support. The length of hospital stay, infection rate, complications and biochemical indexes of the two groups were compared. Results: The hospitalization and hospitalization costs of the treatment group were (23.83 ± 5.91) d and (3.12 ± 1.66) million respectively, the infection rate was 28.6% and the complication rate was 35.7%, which were significantly lower than that of the control group Statistically significant (P <0.05). The biochemical indicators albumin test in the treatment group before and after treatment were not statistically significant (P> 0.05). Blood amylase, AST, blood glucose in the treatment group were significantly improved 14 days after treatment, the difference was statistically significant (P <0.05). CONCLUSION: Early enteral nutrition support can effectively reduce the incidence of complications in the treatment of acute severe pancreatitis. The nutrition status of patients is well improved and the disease recovery is promoted. It is safe and effective and should be popularized.